Another executive is out at Illumina.
The DNA sequencing company said earlier this week that CFO Joydeep Goswami will exit and the position will be taken over by Ankur Dhingra. Prior to Illumina, Dhingra was the CFO at Summit Therapeutics.
In addition, Illumina named Jakob Wedel as chief strategy and corporate development officer, a position Goswami also held.
Illumina has seen a good amount of high-profile turnover in recent months, including in January, when former chief commercial officer Susan Tousi left to take the CEO spot at Delfi Diagnostics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.